Adaptive Biotechnologies Co. (NASDAQ:ADPT) Receives $6.80 Average Price Target from Brokerages
Adaptive Biotechnologies Co. (NASDAQ:ADPT – Get Free Report) has been assigned a consensus rating of “Moderate Buy” from the six research firms that are presently covering the stock, MarketBeat.com reports. Two investment analysts have rated the stock with a hold recommendation and four have given a buy recommendation to the company. The average 12 month […]
More Stories
Bonterra Resources Inc. (OTCMKTS:BONXF) Short Interest Down 50.8% in September
Bonterra Resources Inc. (OTCMKTS:BONXF – Get Free Report) saw a large decline in short interest during the month of September....
Short Interest in Bridges Capital Tactical ETF (NASDAQ:BDGS) Decreases By 50.0%
Bridges Capital Tactical ETF (NASDAQ:BDGS – Get Free Report) was the target of a significant decline in short interest in...
Premium Income 40 Barrier ETF (BATS:JULQ) Plans Dividend of $0.31
Premium Income 40 Barrier ETF (BATS:JULQ – Get Free Report) declared a dividend on Friday, September 27th, NASDAQ reports. Shareholders...
Vest 2 Year Interest Rate Hedge ETF (HYKE) To Go Ex-Dividend on September 30th
Vest 2 Year Interest Rate Hedge ETF (NYSEARCA:HYKE – Get Free Report) announced a dividend on Friday, September 27th, NASDAQ...
Cosan S.A. (NYSE:CSAN) Short Interest Update
Cosan S.A. (NYSE:CSAN – Get Free Report) saw a significant growth in short interest in September. As of September 15th,...
Quisitive Technology Solutions, Inc. (OTCMKTS:QUISF) Short Interest Update
Quisitive Technology Solutions, Inc. (OTCMKTS:QUISF – Get Free Report) saw a large decrease in short interest in September. As of...